AMEVIVE
AMEVIVE
Discontinued
DIN Number
02259052
Drug Class
Human
Market Date
Oct 12, 2004
Company
HC
astellas pharma canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02259052
AIG Number0150402002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L04AA15 ALEFACEPT
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntramuscular
AHFS Classification84:92.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ALEFACEPTActive
Strength: 15 MG / 0.5 ML
Monograph: ALEFACEPT